Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Translocation of Bax to mitochondria induces apoptotic cell death in Indole-3-carbinol (I3C) treated breast cancer cells

Abstract

Epidemiological studies have suggested that the consumption of fruits and vegetables that provide several classes of compounds, including Indole-3-carbinol (I3C), may have chemopreventive activity against breast cancer. Several in vitro and in vivo animal studies also provide convincing evidence for the anti-tumor activity of I3C, however, the molecular mechanism(s) by which I3C exerts its biological effects on breast cancer cells has not been fully elucidated. In this study, we investigated the effects of I3C in Her-2/neu over-expressing MDA-MB-435 breast cancer cells and compared these results with parental cells transfected with control vector. We focused our investigation in elucidating the molecular mechanism(s) by which I3C induces apoptosis in breast cancer cells. Our data show that I3C inhibits breast cancer cell growth in a dose dependent manner in Her-2/neu over-expressing and in normal Her-2/neu expressing cells. Induction of apoptosis was also observed in these cell lines when treated with I3C, as measured by poly (ADP-ribose) polymerase (PARP) and caspase-3 activation. In addition, we found that I3C up-regulates Bax, down-regulates Bcl-2 and, thereby, increased the ratio of Bax to Bcl-2 favoring apoptosis. These results suggest that the alteration in the expression of these genes may play an important role in mediating the biological effects of I3C. Moreover, we also show the cellular localization of Bax by confocal microscopy, which showed diffuse distribution of Bax throughout the cytoplasmic compartment in breast cancer cells in control culture. However, in I3C treated cells, Bax showed a punctate pattern of distribution that was localized in the mitochondria. From these results, we conclude that the over-expression and translocation of Bax to mitochondria causes mitochondrial depolarization and activation of caspases, which may be one of the mechanism(s) by which I3C induces apoptotic processes in I3C treated breast cancer cells. Overall, our present data provide a novel molecular mechanism(s) by which I3C elicits its biological effects on both Her-2/neu over-expressing and with normal Her-2/neu expressing breast cancer cells, suggesting that I3C could be an effective agent in inducing apoptosis in breast cancer cells.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

References

  • A.I.F.C.R. 1997 Food, Nutrition and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Research: Washington, DC, USA. pp.436–446.

  • Baily G, Selivonchick D and Hendricks J. . 1987 Environ. Health Perspective 71: 147–153.

  • Birt DF, Pelling JC and Lepley D. . 1996 Prog. Clin. Biol. Res. 395: 223–234.

  • Bradfield CA and Bjeldanes LF. . 1991 Adv. Exp. Med. Biol. 289: 153–163.

  • Bradlow, Sepkovic D, Mailman J and Osborne M P. . 1997 J. Cell. Biochem. (Suppl) 28–29: 111–116.

  • Broadbent TA and Broadbent HS. . 1998 Curr. Med. Chem. 5: 337–352.

  • Byrd JC, Shinn C, Waselenko JK, Fuchs EJ, Lehman TA, Nguyen PL, Flinn IW, Diehl LF, Sausville E and Grever MR. . 1998 Blood 92: 3804–3816.

  • Chiarugi V, Magnelli L, Cinelli M and Basi G. . 1994 Cell. Mol. Biol. Res. 40: 603–612.

  • Clarke AR, Purdie CA and Harrison DJ. . 1993 Nature 362: 849–852.

  • Cover CM, Hsieh SJ, Tran SH, Hallden G, Kim GS, Bjeldanes LF and Firestone GL. . 1998 J. Biol. Chem. 273: 3838–3847.

  • Cover CM, Hsieh SJ, Cram EJ, Hong C, Riby JE, Bjeldanes LF and Firestone GL. . 1999 Cancer Res. 59: 1244–1251.

  • Darmon AJ, Nicholson DW and Bleackley RC. . 1995 Nature 377: 446–448.

  • Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B and Martinou J-C. . 1999 J. Cell Biol. 144: 891–901.

  • Flagg EW, Coates RJ, Calle EE, Potischman N and Thun MJ. . 2000 Epidemiology 11: 462–468.

  • Freudenheim JL, Marshall JR, Vena JE, Laughlin R, Brasure JR, Swanson MK, Nemoto T and Graham S. . 1996 J. Natl. Cancer Inst. 88: 340–348.

  • Ge X, Yannai S, Rennert G, Gruener N and Fares FA. . 1996 Biochem. Biophys. Res. Commun. 228: 153–158.

  • Gross A, Jockel J, Wei MC and Korsmeyer SJ. . 1998 EMBO J. 17: 3837–3885.

  • Grubbs CJ, Steele VE, Casebolt T, Juliana MM, Eto I, Whitaker LM, Dragnev KH, Kelloff GJ and Lubet RL. . 1995 Anticancer Res. 15: 709–716.

  • Hsu YT and Youle RJ. . 1997 J. Biol. Chem. 272: 13829–13834.

  • Huber WW, McDaniel, Kaderlik, Teitel CH, Lang NP and Kadlubar FF. . 1997 Mutation Res. 376: 115–122.

  • Katdare M, Osborne MP and Telang NT. . 1998 Oncol. Reports 5: 311–315.

  • Kluck RM, Bossy-Wetze IE, Green DR and Newmeyer DD. . 1997 Science 275: 1132–1136.

  • Kojima T, Tanaka T and Mori H. . 1994 Cancer Res. 541: 446–449.

  • Kroemer G. . 1997 Nat. Med. 3: 614–620.

  • Li Y, Bhuiyan M, Mohammad RM and Sarkar FH. . 1998 Oncogene 17: 2915–2920.

  • Loub WD, Wattenberg LW and Davis DW. . 1975 J. Natl. Cancer Inst. 54: 985–988.

  • Miyashita T, Harigai M, Hanada M and Reed JC. . 1994 Cancer Res. 54: 3131–3135.

  • Nicholson DW, Ali A, Thornberry NA and Vaillancourt JP. . 1995 Nature 367: 37–43.

  • Niwa T, Swancek G and HL B. . 1994 Steroids 59: 523–527.

  • Nomura M, Shimizu S, Ito T, Narita M, Matsuda H and Tsujimoto Y. . 1999 Cancer Res. 59: 5542–5548.

  • Oltvai ZN, Milliman CL and Korsmeyer SJ. . 1993 Cell 74: 609–611.

  • Parker BW, Kaur G, Nieves-Neira W, Taimi M, G K, Shimizu T, Losiewicz MD, Pommier Y, Sausville EA and Senderowicz AM. . 1998 Blood 91: 458–465.

  • Philpott NJ, Turner AJ, Scopes J, Westby M, Marsh JC, Gordon-Smith EC, Dalgleish AG and Gibson FM. . 1996 Blood 87: 2244–2251.

  • Ryan JJ, Danish R, Gottieb CA and Clarke MF. . 1993 Mol. Cell Biol. 13: 711–719.

  • Salet C and Moreno G. . 1995 Int. J. Radiat. Biol. 67: 477–480.

  • Salmons GS, Brady HJ, Verwijs-Jansen M, Van JD, Hart AA, Van H, Behren K and Smets LA. . 1997 Int. J. Cancer 71: 959–965.

  • Sedlak ML, Oltvai ZN, Yang E, Wang GK, Boise LH and Thompson CB. . 1995 Proc. Natl. Acad. Sci. 92: 7943–7948.

  • Shertzer HG. . 1984 Chem. Biol. Interact. 48: 81–90.

  • Tan M, Yao J and Yu D. . 1997 Cancer Res. 57: 1199–1205.

  • Tiwari RK, Guo L, Bradlow HL, Telang NT and Osborne MP. . 1994 J. Nat. Cancer Inst. 86: 126–131.

  • Wattenberg LW and Laoub WD. . 1978 Cancer Res. 38: 1410–1413.

  • Wolter KG, Hsu Y-T, Smith CL, Nechustan A, Xi X-G and Youle RJ. . 1997 J. Cell. Biol. 139: 1281–1292.

  • Yu D, Liu B, Tan M, Li J, Wang SS and Hung MC. . 1996 Oncogene 13: 1359–1365.

Download references

Acknowledgements

We sincerely thank Ms Patricia Arlauskas for her editorial assistance. This project was partly funded by a pilot grant from NIEHS center grant (ES 06639) at Wayne State University, and the George Puschelberg Foundation awarded to FH Sarkar. We also thank Dr Kamiar Moin and Linda Mayernik for their invaluable assistance with the confocal microscopic imaging. Center Grants P30ES06639 from the National Institutes of Environmental Health Sciences. We would like to thank Erie Van Buren, Evano Piasentin and Dr Stephen Lerman for their assistance in the flow cytometry core facility, supported by the grant. P30CA22453 from the National Cancer Institute which supports this core facility at Wayne State University School of Medicine.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wahidur Rahman, K., Aranha, O., Glazyrin, A. et al. Translocation of Bax to mitochondria induces apoptotic cell death in Indole-3-carbinol (I3C) treated breast cancer cells. Oncogene 19, 5764–5771 (2000). https://doi.org/10.1038/sj.onc.1203959

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203959

Keywords

This article is cited by

Search

Quick links